Dynulta Tablet

Dynulta Tablet contains sucroferric oxyhydroxide as its active component. It is a phosphate binder indicated for hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Hyperphosphatemia involves abnormally elevated blood phosphate levels, a frequent complication of CKD. The medication contains iron, which may benefit patients with CKD who commonly develop iron deficiency anaemia. The dual action of iron supplementation and phosphate binding addresses iron deficiency and supports red blood cell production.

Do not take Dynulta Tablet if allergic to it or any of its components. Allergic reactions range from mild to severe and may include rash, itching, swelling, dizziness, or difficulty breathing.

Use Dynulta Tablet with caution in patients with iron overload disorders such as haemochromatosis, or those receiving high-dose intravenous iron therapy.

Safety and effectiveness of this medicine in paediatric patients have not been established, as use in this population has not been extensively studied.

Treatment of high phosphate levels in the blood

Dynulta Tablet is a medication that effectively lowers elevated phosphate levels in the blood, primarily in patients with chronic kidney disease (CKD) who are on dialysis. By binding to dietary phosphate in the gastrointestinal tract, this medication prevents its absorption into the bloodstream, thereby reducing the overall phosphate burden. This helps to manage hyperphosphatemia, a common complication of CKD, and minimize associated risks such as bone disease and cardiovascular complications.

To use Dynulta Tablet, follow the instructions provided by your healthcare professional or the guidelines on the medication packaging. Typically, this medication is taken orally as chewable tablets with meals or shortly after eating. The dosage and frequency of administration will depend on your specific medical condition and individual needs. It is important to chew the tablets thoroughly before swallowing. You may consult your healthcare provider for alternative administration options if you have difficulty chewing.

Dynulta tablets cause some side effects like all medications, although not everyone will experience them. Serious: Allergic reaction Breathlessness Black stools Common: Diarrhea Discolored feces (usually dark or black) Constipation Nausea Vomiting Stomach pain or discomfort Indigestion or heartburn

When taking Dynulta Tablet, it is important to note that allergic reactions are rare, but when to occur it requires immediate medical attention for symptoms like rash, itching, swelling, difficulty breathing, or dizziness develop. This medication contains iron and may contribute to iron overload, particularly in at-risk individuals, necessitating regular monitoring of iron levels. Caution should be exercised in individuals with gastrointestinal disorders. The safety during pregnancy, breastfeeding, and in pediatric patients has not been well established. Precautions should be taken to minimize the risk of tooth discoloration by performing good oral hygiene practices. Regular communication with healthcare providers is essential to address concerns and promptly report any concerning symptoms or side effects.